CHI3L1 and metabolic dysfunction-associated steatohepatitis: In a NASH mouse model, Chi3l1 has also been shown to be associated with disease progression through regulating fibrosis-promoting factors via macrophages and directly activating hepatic stellate cells (HSCs) via the receptor IL13Rα2 [81].